Jai Singh InspectorProfile


This InspectorProfile is a report of relevant audit-related information on Jai Singh, a U.S. Food & Drug Administration investigator who primarily conducts inspections in the area of Human Drugs.

Product Description

This InspectorProfile report is updated through and lists Jai Singh's 35 inspections in 6 countries: United States, China, India, Korea (the Republic of), Belgium, and France.

FDA audits are stressful. Whether you are issued a 483 depends largely on your compliance with GxP and predicate rules; but it can also depend on the Agency's current focus and the tendencies of your specific investigator(s). FDAzilla has curated Jai Singh's inspection information so that you can mitigate investigator-related risks.

Below is an example of what a FDAzilla InspectorProfile report contains; This is not the actual data for Jai Singh.

Example Report

Jai Singh FDA InspectorProfile Overview Example
Jai Singh FDA InspectorProfile Metrics Example
Jai Singh FDA InspectorProfile Citations Example
Jai Singh FDA InspectorProfile Inspections List
Add To Cart3 of Singh 483s in stock

Product details

  • Jai Singh's metrics:
    • 483 issue rate, total inspections, total 483s
    • Most common citations (based on CFR), CFR description, and citation frequency
    • Total inspections, total 483s
    • Longest / shortest inspection in duration - all time, last year
    • Total warning letters
  • Inspection details for each inspection (since 2000) Jai Singh has conducted including:

Note: The EIR and 483 documents are sold separately.

Add To Cart3 of Jai's 483s Available Now.